Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Kroboth

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Drug Intelligence & Clinical Pharmacy|January 1, 1987
Conceptual issues in designing a clinical scientist programR P Juhl, P D Kroboth
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1998
Simplified procedure for measurement of serum dehydroepiandrosterone and its sulfate with gas chromatography-ion trap mass spectrometry and selected reaction monitoringM A Zemaitis, P D Kroboth
Journal of Clinical Psychopharmacology|October 1, 1989
Relationship of triazolam clearance to alpha-1 acid glycoprotein concentrationsP D Kroboth, R B Smith
Drug Intelligence & Clinical Pharmacy|December 1, 1987
Pentoxifylline in end-stage renal diseaseM R Silver, P D Kroboth
Psychopharmacology Bulletin|January 1, 1997
Progesterone: does it affect response to drug?P D Kroboth, J W McAuley
Clinical Pharmacokinetics|June 1, 1989
Pharmacokinetics of the newer benzodiazepinesP D Garzone, P D Kroboth
Journal of Clinical Pharmacology|May 1, 1988
Basic concepts in pharmaco-dynamic modelingT L Schwinghammer, P D Kroboth
Psychopharmacology|January 1, 1987
Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effectsR B Smith, P D Kroboth
Drug Intelligence & Clinical Pharmacy|July 1, 1983
New drug evaluations. TriazolamP D Kroboth, R P Juhl
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1984
Use of procainamide in chronic ambulatory peritoneal dialysis: report of a caseP D Kroboth, K Mitchum, J B Puschett
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Drug Intelligence & Clinical Pharmacy|January 1, 1987
Conceptual issues in designing a clinical scientist programR P Juhl, P D Kroboth
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1998
Simplified procedure for measurement of serum dehydroepiandrosterone and its sulfate with gas chromatography-ion trap mass spectrometry and selected reaction monitoringM A Zemaitis, P D Kroboth
Journal of Clinical Psychopharmacology|October 1, 1989
Relationship of triazolam clearance to alpha-1 acid glycoprotein concentrationsP D Kroboth, R B Smith
Drug Intelligence & Clinical Pharmacy|December 1, 1987
Pentoxifylline in end-stage renal diseaseM R Silver, P D Kroboth
Psychopharmacology Bulletin|January 1, 1997
Progesterone: does it affect response to drug?P D Kroboth, J W McAuley
Clinical Pharmacokinetics|June 1, 1989
Pharmacokinetics of the newer benzodiazepinesP D Garzone, P D Kroboth
Journal of Clinical Pharmacology|May 1, 1988
Basic concepts in pharmaco-dynamic modelingT L Schwinghammer, P D Kroboth
Psychopharmacology|January 1, 1987
Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effectsR B Smith, P D Kroboth
Drug Intelligence & Clinical Pharmacy|July 1, 1983
New drug evaluations. TriazolamP D Kroboth, R P Juhl
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1984
Use of procainamide in chronic ambulatory peritoneal dialysis: report of a caseP D Kroboth, K Mitchum, J B Puschett
Pageof 6